Abstract #2808

Monitoring Breast Cancer Response to Neoadjuvant Chemotherapy by Diffusion Tensor Imaging

Edna Furman-Haran¹, Noam Nissan², Hadassa Degani², and Julia Camps Herrero³

¹Department of Biological Services, The Weizmann Institute of Science, Rehovot, Israel, ²Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel, ³Radiology, Hospital de la Ribera, Alzira, Spain

We have evaluated the ability of diffusion tensor imaging (DTI) to assess breast cancer response to neoadjuvant chemotherapy. Changes in lesion size and diffusion parameters in response to therapy were determined. Diameter and volume measurement derived from DTI were compared to those derived from dynamic contrast enhanced (DCE) MRI and to post surgery pathological reports. A high congruence was found between DTI and DCE-MRI for tumor size and response evaluation, with both methods showing a good agreement with pathology results.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.